Man Group plc Buys Shares of 19,415 Danaher Corporation $DHR

Man Group plc acquired a new stake in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 19,415 shares of the conglomerate’s stock, valued at approximately $13,980,000.

A number of other institutional investors have also recently added to or reduced their stakes in DHR. BlackRock Inc. acquired a new position in shares of Danaher during the 2nd quarter worth $10,492,520,000. State Street Corp lifted its holdings in shares of Danaher by 1.7% in the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors grew its position in shares of Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after purchasing an additional 1,334,221 shares in the last quarter. Finally, Wellington Management Group LLP increased its stake in shares of Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $215.74 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market capitalization of $151.67 billion, a price-to-earnings ratio of 38.32, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a 50 day moving average price of $198.69 and a 200 day moving average price of $192.35.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the prior year, the firm posted $0.77 EPS. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analyst Weigh In

DHR has been the topic of a number of recent research reports. HSBC reduced their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Royal Bank Of Canada boosted their price target on Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a report on Wednesday, July 22nd. Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. DZ Bank assumed coverage on Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Finally, Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.